API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2024/03/26/2852256/0/en/Verrica-Pharmaceuticals-Announces-that-YCANTH-Receives-New-Chemical-Entity-Status-and-Orange-Book-Listing-from-the-FDA.html
https://www.globenewswire.com//news-release/2023/09/27/2750291/0/en/Verrica-Pharmaceuticals-to-Host-Virtual-KOL-Event-Discussing-the-Approval-of-YCANTH-Cantharidin-Topical-Solution-for-the-Treatment-of-Molluscum-on-October-11-2023.html
https://endpts.com/fda-approves-verricas-skin-infection-treatment-enters-into-non-binding-term-sheet-for-125m-loan/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-verricas-skin-disease-treatment-2023-07-21/
https://www.globenewswire.com/news-release/2020/09/23/2098298/0/en/JAMA-Dermatology-Publishes-Results-from-Verrica-s-Two-Pivotal-Phase-III-CAMP-Cantharidin-Application-in-Molluscum-Patients-Trials.html
https://www.globenewswire.com/news-release/2020/06/29/2054986/0/en/Verrica-Pharmaceuticals-Provides-Regulatory-Update-on-VP-102.html#:~:text=Verrica%20Pharmaceuticals%20Provides%20Regulatory%20Update%20on%20VP%2D102,-Email%20Print%20Friendly&text=The%20letter%20states%20that%20there,on%20the%20information%20under%20review.
https://www.biospace.com/article/releases/verrica-pharmaceuticals-announces-presentation-of-positive-data-from-clinical-trials-of-vp-102-at-the-2019-39th-annual-fall-clinical-dermatology-conference/?s=95
https://www.biospace.com/article/releases/verrica-pharmaceuticals-announces-presentation-of-positive-data-from-clinical-trials-of-vp-102-at-the-2019-39th-annual-fall-clinical-dermatology-conference/?s=95
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-oldest-pharma-company-bengal-chemicals-turns-profitable-after-64-years-but-faces-privatisation-blues/articleshow/59360661.cms